Menu

Artificial intelligence in pharmaceutical development and manufacturing

Articles 7 June 2023

The application cases of artificial intelligence to the pharmaceutical sector are vast. Besides its accessibility and simplicity of use, artificial intelligence has significant advantages: less variability in test results, less verification activity in the case of a validated system, improved process knowledge… Chat GPT is in itself a good example of the advantages that AI may bring to the sector.

Cécile Théard-Jallu, partner, and Grégoire Froussart, associate, wrote an insight on the topic, released in the latest edition of PharmaNetwork.

Read article

Authors

Cécile
Théard-Jallu
Partner
Grégoire
Froussart
Lawyer - Senior
Would you like to be kept up to date with the latest news on this topic?
Sign up to receive e-mails of new articles, events, analysis... on the subjects most relevant to you.
Create your customized watch

Receive news on the topics
that matter to you

Further information

Discover our professionals

Francine
Le Péchon-Joubert
Partner
Lionel
Attal
Partner
Julia
Pirinoli
Lawyer
Anne
Maréchal
Partner

Latest news

Publications 14 April 2026
Annual report – « 25 years of making an impact »
seniors-counsels-avocats-2026
Firm Life 9 April 2026
Magalie Dejoux, Céline Forthomme, Sophie Gibert and Diego Romero have been promoted to Senior Counsels at De Gaulle Fleurance
Firm Life 8 April 2026
De Gaulle Fleurance EMEA promotes Racha Wylde to Partner
Firm Life 7 April 2026
Charlotte Hébert-Salomon, who serves clients in the tech sector, has been promoted to partner at De Gaulle